This study was presented in part at the annual meeting of the American Society of Dermatopathology, Dallas, Texas, December 4–6, 1991.
Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors
Article first published online: 27 APR 2006
Journal of Cutaneous Pathology
Volume 20, Issue 1, pages 15–20, February 1993
How to Cite
Cohen, P. R., Rapini, R. P. and Farhood, A. I. (1993), Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors. Journal of Cutaneous Pathology, 20: 15–20. doi: 10.1111/j.1600-0560.1993.tb01243.x
- Issue published online: 27 APR 2006
- Article first published online: 27 APR 2006
- Accepted May 1, 1992
The human hematopoietic progenitor cell antigen is known as CD34. This antigen is present on normal bone marrow progenitor cells and vaseular endothelial cells. We used the monoclonal antibody auti-CD34 and immunoperoxidase staining techniques to evaluate the expression of CD34 in benign and malignant vascular and spindle cell tumors. All of the 42 vascular lesions, except two of three lesions of intravascular papillary endothelial hyperplasia, demonstrated diffuse membraneous staining of moderate lo strong intensity of their endothelial cells. Also, normal placentas (five) showed similar staining. All neurofibromas (12), three of five neuromas, and one of four neurilemmomas revealed moderate to strong, diffuse, membraneous staining. Five of eight piloleiomyomas, two of seven angiolciomyomas, and one of five uterine leiomyomas showed focal to dilluse, and weak to moderate, membraneous staining in the smooth muscle component. Six dermatofibrosarcoma protuberans were studied: generalized, strongly positive membraneous staining was present in four. All specimens showed staining of the normal endothelial cells and the cells surrounding the hair follicles (bulge area), sebaceous glands, and eccrine glands. No staining was demonstrated in any of the following fibrohistiocytic tumors: atypical fibroxanthomas (two), fibrous dermatofibromas (23), giant cell tumor of tendon sheath (one), and hemosiderotic dermatofibromas (18). Melanocytic tumors (Spitz nevi (three) and spindle cell superficial spreading malignant melanoma (one)], Merkel cell carcinomas (six), and spindle cell squamous cell carcinomas (two) did not stain with anti-CD34. Glomus tumors (two) and a hemangiopericytoma were also negative except for their vascular channels. This study demonstates that reactivity with anti-CD34 is not limited to normal vascular endothelial cells and their neoplasms.